Status:
UNKNOWN
Fecal Microbiota Transplantation for Health Improvement (TFM3)
Lead Sponsor:
Federal Research and Clinical Center of Physical-Chemical Medicine
Conditions:
Ulcerative Colitis
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Search for mechanisms of the effect of fecal transplantation on a healthy organism and various nosological forms.
Detailed Description
Objectives of the study: 1. To select donors of fecal samples for carrying out the procedure of fecal transplantation of microbiota to patients with various nosological forms. 2. To select healthy vo...
Eligibility Criteria
Inclusion
- the age of patients - from 18 to 75 years, both sexes;
- Patients with:
- antibiotic-associated colitis,
- inflammatory bowel diseases (ulcerative colitis, Crohn's disease),
- diseases caused by C. difficile infection,
- a syndrome of impaired intestinal absorption,
- irritable bowel syndrome,
- celiac disease (severe form),
- metabolic syndrome, including diabetes mellitus type II,
- Atopic dermatitis with damage to the mucous membrane of the colon,
- hepatitis of various etiologies,
- cirrhosis of the liver of various etiologies
- pancreatitis of various etiologies,
- Absence of contraindications to gastroscopy
- informed consent of the patient for the transplant procedure
Exclusion
- the presence of a concomitant chronic infectious or neoplastic disease in the patient
- Patients with a proven allergy to foods not excluded from the donor's diet
- absence of the patient for one or more intermediate stages of the examination.
- informed refusal to continue therapy
Key Trial Info
Start Date :
May 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04011943
Start Date
May 21 2018
End Date
December 1 2020
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FRCC PCM
Moscow, Russia